These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4106335)

  • 1. Mechanism of skin graft enhancement in the mouse.
    McKenzie IF; Koene R; Winn HJ
    Transplant Proc; 1971 Mar; 3(1):711-3. PubMed ID: 4106335
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive enhancement of skin heterografts.
    Jeekel J; Westbroek DL
    Transplant Proc; 1971 Mar; 3(1):714-6. PubMed ID: 4937964
    [No Abstract]   [Full Text] [Related]  

  • 4. Humoral antibody in allograft reactions.
    Winn HJ
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression, virus and oncogenesis in mice.
    Nehlsen SL
    Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts.
    Franco DJ; Monaco AP
    Surg Forum; 1968; 19():175-7. PubMed ID: 4887902
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of immunological enhancement for the growth of autochthonous tumors.
    Hellström I; Hellström KE
    Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological enhancement of skin grafts in the mouse.
    Jeekel JJ; McKenzie IF; Winn HJ
    J Immunol; 1972 Apr; 108(4):1017-24. PubMed ID: 4112414
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various effects of heterologous antithymus- and antilymphocyte serum on the development of the graft-vs-host reaction].
    Biege G; von Broen B
    Exp Pathol (Jena); 1970; 4(4):211-6. PubMed ID: 4399294
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance and enhancement in organ transplantation.
    Brent L
    Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of ovarian graft survival in mature rats.
    Yussman MA; Hines EC
    Surg Forum; 1969; 20():406-8. PubMed ID: 4910616
    [No Abstract]   [Full Text] [Related]  

  • 15. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum.
    Hasek M; Skamene E; Karakoz I; Chutná J; Nouza K; Bubeník J; Sovová V; Nĕmec M; Jonák J
    Folia Biol (Praha); 1968; 14(6):411-24. PubMed ID: 4236901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicity of hyperimune rabbit-mouse thymus antiserum].
    Biege G; von Broen B
    Exp Pathol (Jena); 1970; 4(1):1-5. PubMed ID: 4107737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.